Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current HIV/AIDS Reports
Erschienen in: Current HIV/AIDS Reports 6/2021

18.11.2021 | Central Nervous System and Cognition (S Spudich, Section Editor)

Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV

verfasst von: Jacqueline Hoare, Tatum Sevenoaks, Bulelwa Mtukushe, Taryn Williams, Sarah Heany, Nicole Phillips

Erschienen in: Current HIV/AIDS Reports | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of the review

By reviewing the most recent common mental health disorders (CMHD) studies in people living with HIV (PLWH) (2018-2020), this review discusses the prevalence of CMHD, factors associated with CMHD in PLWH, mental health in PLWH from vulnerable groups, the impact of CMHD on HIV disease progression and adherence to antiretroviral therapy and the efficacy of different treatment approaches.

Recent findings

After screening for eligibility 142 studies were included in the final systematic review. Only 27% of studies were conducted in Sub-Saharan Africa, which carries the highest burn of HIV disease globally. Despite the well-established increased risk of CMHD in PLWH, the current prevalence remains high, with studies reporting 28%-62% of PLWH having mental health symptoms.

Conclusion

Despite the significant challenges that CMHDs present to successful HIV treatment, there are many mental health treatments and interventions which can improve outcomes in PLWH and opportunities to task-shift and integrate mental health care with HIV care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Catalan J, et al. HIV infection and mental health: suicidal behaviour–systematic review. Psychol Health Med. 2011;16(5):588–611.PubMedCrossRef
2.
Remien RH, et al. Mental health and HIV/AIDS: the need for an integrated response. AIDS (London, England). 2019;33(9):1411.CrossRef
3.
4.
Waldron EM, et al. Mental Health in Women Living With HIV: The Unique and Unmet Needs. J Int Assoc Providers AIDS Care (JIAPAC). 2021;20:2325958220985665.
5.
Kapetanovic S, et al. Mental health of HIV-seropositive women during pregnancy and postpartum period: a comprehensive literature review. AIDS Behav. 2014;18(6):1152–73.PubMedPubMedCentralCrossRef
6.
Mitchell J, et al. Intimate partner violence, HIV, and mental health: a triple epidemic of global proportions. Int Rev Psychiatry. 2016;28(5):452–63.PubMedCrossRef
7.
Koegler E, Kennedy CE. A scoping review of the associations between mental health and factors related to HIV acquisition and disease progression in conflict-affected populations. Confl Heal. 2018;12(1):1–22.
8.
Bockting W, et al. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diab Obes. 2016;23(2):188.CrossRef
9.
Smith HJ, Topp SM, Hoffmann CJ, Ndlovu T, Charalambous S, Murray L, Kane J, Sikazwe I, Muyoyeta M, Herce ME. Addressing common mental health disorders among incarcerated people living with HIV: Insights from implementation science for service integration and delivery. Curr HIV/AIDS Rep. 2020;17(5):438–449. https://​doi.​org/​10.​1007/​s11904-020-00518-x.
10.
Berg MB, Mimiaga MJ, Safren SA. Mental health concerns of HIV-infected gay and bisexual men seeking mental health services: an observational study. AIDS Patient Care STDs. 2004;18(11):635–43.PubMedCrossRef
11.
Rezaei S, et al. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care. 2019;9(4):404–12.PubMed
12.
Nanni MG, et al. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015;17(1):1–11.CrossRef
13.
Collins PY, et al. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS (London, England). 2006;20(12):1571.CrossRef
14.
Rueda S, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453.PubMedPubMedCentralCrossRef
15.
Jackson-Best F, Edwards N. Stigma and intersectionality: a systematic review of systematic reviews across HIV/AIDS, mental illness, and physical disability. BMC Public Health. 2018;18(1):1–19.CrossRef
16.
17.
18.
19.
Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc. 2006:359–63.
20.
Tuthill EL, et al. A dyadic investigation of relationship dynamics and depressive symptoms in HIV-affected couples in Malawi. AIDS Behav. 2019;23(12):3435–43.PubMedPubMedCentralCrossRef
21.
Rooney AS, et al. Depression and aging with HIV: associations with health-related quality of life and positive psychological factors. J Affect Disord. 2019;251:1–7.PubMedPubMedCentralCrossRef
22.
Jiang H, et al. Negative life events and major depressive disorder among HIV-positive individuals in Guangdong, China: A cross-sectional study. Medicine. 2019;98(37):e17174.PubMedPubMedCentralCrossRef
23.
Huynh V-AN, et al. Quality of life, depression and correlates in HIV+ people at An Hoa Clinic, Ho Chi Minh City. AIDS Care. 2019;31(5):582–8.PubMedCrossRef
24.
Garfin DR, et al. Depression, social support, and stigma as predictors of quality of life over time: results from an Asha-based HIV/AIDS intervention in India. AIDS Care. 2019;31(5):563–71.PubMedPubMedCentralCrossRef
25.
26.
Fabian KE, et al. Moderating factors in an Anti-stigma intervention for African American women with HIV in the United States: a secondary analysis of the unity trial. AIDS Behav. 2019;23(9):2432–42.PubMedPubMedCentralCrossRef
27.
De Francesco D, et al. Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individuals. Int J STD AIDS. 2019;30(5):440–6.PubMedCrossRef
28.
Zeng C, et al. A structural equation model of perceived and internalized stigma, depression, and suicidal status among people living with HIV/AIDS. BMC Public Health. 2018;18(1):1–11.CrossRef
29.
Wang W, et al. Psychological pathway to suicidal ideation among people living with HIV/AIDS in China: A structural equation model. Psychiatry Res. 2018;260:255–61.PubMedCrossRef
30.
Tran BX, et al. Depression and quality of life among patients living with HIV/AIDS in the era of universal treatment access in Vietnam. Int J Environ Res Public Health. 2018;15(12):2888.PubMedCentralCrossRef
31.
Rane MS, et al. Depression and anxiety as risk factors for delayed care-seeking behavior in HIV positive individuals in South Africa. Clin Infect Dis. 2018;67(9):1411–8.PubMedPubMedCentralCrossRef
32.
Mills JC, et al. Cumulative burden of depression and all-cause mortality in women living with human immunodeficiency virus. Clin Infect Dis. 2018;67(10):1575–81.PubMedPubMedCentralCrossRef
33.
McIntosh RC, et al. Resting-state connectivity and spontaneous activity of ventromedial prefrontal cortex predict depressive symptomology and peripheral inflammation in HIV. J Neurovirol. 2018;24(5):616–28.PubMedPubMedCentralCrossRef
34.
McGowan JA, et al. Resilience and physical and mental well-being in adults with and without HIV. AIDS Behav. 2018;22(5):1688–98.PubMedCrossRef
35.
López J, Shacham E, Brown T. Suicidal ideation persists among individuals engaged in HIV care in the era of antiretroviral therapy. AIDS Behav. 2018;22(3):800–5.PubMedCrossRef
36.
Looby SE, et al. Association Between HIV-Status and Psychological Symptoms in Perimenopausal Women. Menopause (New York, NY). 2018;25(6):648.CrossRef
37.
Goodin BR, et al. Intersectional health-related stigma in persons living with HIV and chronic pain: implications for depressive symptoms. AIDS Care. 2018;30(sup2):66–73.PubMedPubMedCentralCrossRef
38.
Adams LM, et al. Using the Center for Epidemiologic Studies Depression Scale to assess depression in women with HIV and women at risk for HIV: Are somatic items invariant? Psychol Assess. 2018;30(1):97.PubMedCrossRef
39.
Terloyeva D, et al. Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study. PLoS One. 2018;13(3):e0193976.PubMedPubMedCentralCrossRef
40.
Nyamukoho E, et al. Depression among HIV positive pregnant women in Zimbabwe: a primary health care based cross-sectional study. BMC Pregnancy Childbirth. 2019;19(1):1–7.CrossRef
41.
Mokhele I, et al. Prevalence and predictors of postpartum depression by HIV status and timing of HIV diagnosis in Gauteng,South Africa. PLoS One. 2019;14(4):e0214849.PubMedPubMedCentralCrossRef
42.
Al Madhani A, et al. Prevalence and correlates of depressive symptoms among people living with HIV attending tertiary care hospitals in Oman. Pan Afr Med J. 2020;37:90.PubMedPubMedCentralCrossRef
43.
Visser M, Hlungwani AJ. Maternal HIV status disclosure to young uninfected children: psychological variables of the mother. Afr J AIDS Res. 2020;19(1):48–56.PubMedCrossRef
44.
Fodjo JNS, et al. Impact of the COVID-19 pandemic on the medical follow-up and psychosocial well-being of people living with HIV: A cross-sectional survey. JAIDS J Acquir Immune Defic Syndr. 2020;85(3):257–62.CrossRef
45.
Ophinni Y, et al. Suicidal ideation, psychopathology and associated factors among HIV-infected adults in Indonesia. BMC Psychiatry. 2020;20:1–10.
46.
Metral M, et al. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population? HIV Med. 2020;21(5):342–8.PubMedCrossRef
47.
Marbaniang I, et al. The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India. BMC Public Health. 2020;20(1):1–9.CrossRef
48.
Huang Y, et al. HIV-related stress experienced by newly diagnosed people living with HIV in china: A 1-year longitudinal study. Int J Environ Res Public Health. 2020;17(8):2681.PubMedCentralCrossRef
49.
Garrido-Hernansaiz H, Alonso-Tapia J. Predictors of anxiety and depression among newly diagnosed people living with HIV: A longitudinal study. Scand J Psychol. 2020;61(5):616–24.PubMedCrossRef
50.
Camara A, et al. Anxiety and depression among HIV patients of the infectious disease department of Conakry University Hospital in 2018. Epidemiol Infect. 2020;148:e8.PubMedPubMedCentralCrossRef
51.
Tyree GA, et al. Clinical correlates of depression chronicity among people living with HIV: What is the role of suicidal ideation? J Affect Disord. 2019;258:163–71.PubMedPubMedCentralCrossRef
52.
So-Armah K, et al. Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort study. HIV Med. 2019;20(5):317–29.PubMedPubMedCentralCrossRef
53.
Shim E-J, et al. Suicide risk in persons with HIV/AIDS in South Korea: a partial test of the interpersonal theory of suicide. Int J Behav Med. 2019;26(1):38–49.PubMedCrossRef
54.
Ruffieux Y, et al. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017. J Int AIDS Soc. 2019;22(8):e25339.PubMedPubMedCentralCrossRef
55.
Ogburn DF, et al. Depression, ART adherence, and receipt of case management services by adults with HIV in North Carolina, medical monitoring project, 2009–2013. AIDS Behav. 2019;23(4):1004–15.PubMedCrossRef
56.
Nyongesa MK, et al. Prevalence and correlates of depressive symptoms among adults living with HIV in rural Kilifi, Kenya. BMC Psychiatry. 2019;19(1):1–10.CrossRef
57.
Niu L, et al. Longitudinal trajectories of emotional problems and unmet mental health needs among people newly diagnosed with HIV in China. J Int AIDS Soc. 2019;22(8):e25332.PubMedPubMedCentralCrossRef
58.
Motumma A, et al. Prevalence and associated factors of common mental disorders among adult patients attending HIV follow up service in Harar town, Eastern Ethiopia: a cross-sectional study. BMC Psychol. 2019;7(1):1–9.CrossRef
59.
Mills JC, et al. The impact of cumulative depression along the HIV care continuum in women living with HIV during the era of universal antiretroviral treatment. JAIDS J Acquir Immune Defic Syndr. 2019;82(3):225–33.PubMedCrossRef
60.
61.
Jiang H, et al. Prevalence of and factors associated with major depressive disorder among HIV-positive individuals in Guangdong, China. J Affect Disord. 2019;246:474–9.PubMedCrossRef
62.
Heron JE, et al. The prevalence and risk of non-infectious comorbidities in HIV-infected and non-HIV infected men attending general practice in Australia. PLoS One. 2019;14(10):e0223224.PubMedPubMedCentralCrossRef
63.
Beer L, et al. Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States. Aids. 2019;33(11):1781–7.PubMedCrossRef
64.
Wang W, et al. Psychosocial health and suicidal ideation among people living with HIV/AIDS: A cross-sectional study in Nanjing, China. PloS one. 2018;13(2):e0192940.PubMedPubMedCentralCrossRef
65.
Thai TT, et al. Symptoms of depression in people living with HIV in Ho Chi Minh City, Vietnam: prevalence and associated factors. AIDS Behav. 2018;22(1):76–84.PubMedPubMedCentralCrossRef
66.
Swendeman D, et al. Correction: Gender disparities in depression severity and coping among people living with HIV/AIDS in Kolkata, India. Plos one. 2019;14(2):e0213093.PubMedPubMedCentralCrossRef
67.
Shearer K, et al. Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg,South Africa. Plos one. 2018;13(9):e0203797.PubMedPubMedCentralCrossRef
68.
Nolan C, et al. Depression screening in HIV-positive Tanzanian adults: comparing the PHQ-2, PHQ-9 and WHO-5 questionnaires. Global Mental Health. 2018;5:e38.PubMedPubMedCentralCrossRef
69.
Malava JK. Prevalence and correlates of probable depression diagnosis and suicidal ideation among patients receiving HIV care in Lilongwe,Malawi. Malawi Med J. 2018;30(4):236–42.PubMedPubMedCentralCrossRef
70.
Lu H-F, et al. Prevalence and predictors of depression among people living with HIV/AIDS: a national study. Nurs Res. 2018;67(5):379–86.PubMedCrossRef
71.
Liu H, et al. Identifying factors associated with depression among men living with HIV/AIDS and undergoing antiretroviral therapy: a cross-sectional study in Heilongjiang, China. Health Qual Life Outcomes. 2018;16(1):1–10.CrossRef
72.
Onono M, Odwar T, Abuogi L, Owuor K, Helova A, Bukusi E, Turan J, Hampanda K. Effects of depression, stigma and intimate partner violence on postpartum women's adherence and engagement in HIV care in Kenya. AIDS Behav. 2020;24(6):1807–1815. https://​doi.​org/​10.​1007/​s10461-019-02750-y.
73.
Brown MJ, Qian Y, Harrison S, Haider MR, Conserve DF, Deming M, Zhang J, Li X. Age and sex disparities in sexual trauma, depressive symptoms, and antiretroviral adherence among people living with HIV in the deep South: A mediation analysis. Arch Sex Behav. 2021;50(4):1805–1816. https://​doi.​org/​10.​1007/​s10508-020-01811-x.
74.
Pokhrel KN, et al. Investigating the impact of a community home-based care on mental health and anti-retroviral therapy adherence in people living with HIV in Nepal: a community intervention study. BMC Infect Dis. 2018;18(1):1–9.CrossRef
75.
Paulus DJ, et al. Trajectory of change in anxiety sensitivity in relation to anxiety, depression, and quality of life among persons living with HIV/AIDS following transdiagnostic cognitive-behavioral therapy. Cogn Behav Ther. 2020;49(2):149–63.PubMedCrossRef
76.
Padilla M, et al. Mental health, substance use and HIV risk behaviors among HIV-positive adults who experienced homelessness in the United States–Medical Monitoring Project, 2009–2015. AIDS Care. 2020;32(5):594–9.PubMedCrossRef
77.
Crockett KB, et al. Brief Report: Linking Depressive Symptoms to Viral Nonsuppression Among Women With HIV Through Adherence Self-Efficacy and ART Adherence. JAIDS J Acquir Immune Defic Syndr. 2020;83(4):340–4.PubMedCrossRef
78.
Van Coppenhagen B, Duvenage HS. Prevalence of depression in people living with HIV and AIDS at the Kalafong Provincial Tertiary Hospital Antiretroviral Clinic. S Afr J Psychiatry. 2019;25(1):1–6.
79.
McMahon JM, et al. Syndemic factors associated with adherence to antiretroviral therapy among HIV-positive adult heterosexual men. AIDS Res Ther. 2019;16(1):1–10.CrossRef
80.
Mannes ZL, et al. The association between symptoms of generalized anxiety disorder and appointment adherence, overnight hospitalization, and emergency department/urgent care visits among adults living with HIV enrolled in care. J Behav Med. 2019;42(2):330–41.PubMedCrossRef
81.
Yijia L, et al. Neuropsychological changes in efavirenz switch regimens. AIDS (London, England). 2019;33(8):1307.CrossRef
82.
Levy ME, et al. Pharmacologic Treatment of Psychiatric Disorders and Time With Unsuppressed HIV Viral Load in a Clinical HIV Cohort. JAIDS J Acquir Immune Defic Syndr. 2019;82(3):329–41.PubMedCrossRef
83.
Jiang M, et al. Social support, stigma, and the mediating roles of depression on self-reported medication adherence of HAART recipients in China. AIDS Care. 2019;31(8):942–50.PubMedCrossRef
84.
Hill LM, et al. Drug use mediates the relationship between depressive symptoms and adherence to ART among recently incarcerated people living with HIV. AIDS Behav. 2019;23(8):2037–47.PubMedPubMedCentralCrossRef
85.
Gokhale RH, et al. Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009–2014. AIDS Behav. 2019;23(12):3452–9.PubMedCrossRef
86.
Yu Y, et al. Medication adherence to antiretroviral therapy among newly treated people living with HIV. BMC Public Health. 2018;18(1):1–8.CrossRef
87.
Tareke M, Addisu F, Abate A. Depression among patients attending antiretroviral treatment program in public health facilities in Bahir Dar City, Ethiopia. J Affect Disord. 2018;232:370–4.PubMedCrossRef
88.
Sumari-de Boer M, et al. Efavirenz is related to neuropsychiatric symptoms among adults, but not among adolescents living with human immunodeficiency virus in Kilimanjaro. Tanzania Trop Med Int Health. 2018;23(2):164–72.PubMedCrossRef
89.
Rodriguez VJ, et al. Suicidality among nonadherent patients living with HIV in Buenos Aires, Argentina: prevalence and correlates. AIDS Care. 2018;30(11):1380–7.PubMedPubMedCentralCrossRef
90.
Pence BW, et al. Association of increased chronicity of depression with HIV appointment attendance, treatment failure, and mortality among HIV-infected adults in the United States. JAMA Psychiatry. 2018;75(4):379–85.PubMedPubMedCentralCrossRef
91.
Nyamathi A, et al. Relationships among adherence and physical and mental health among women living with HIV in rural India. AIDS Behav. 2018;22(3):867–76.PubMedPubMedCentralCrossRef
92.
Myezwa H, et al. Disability and health outcomes–from a cohort of people on long-term antiretroviral therapy. SAHARA-J: J Soc Aspects HIV/AIDS. 2018;15(1):50–9.CrossRef
93.
Gebremichael DY, et al. Gender difference in health related quality of life and associated factors among people living with HIV/AIDS attending anti-retroviral therapy at public health facilities, western Ethiopia: comparative cross sectional study. BMC Public Health. 2018;18(1):1–11.CrossRef
94.
Babowitch JD, et al. Association of depressive symptoms with lapses in antiretroviral medication adherence among people living with HIV: a test of an indirect pathway. AIDS Behav. 2018;22(10):3166–74.PubMedCrossRef
95.
Hussen SA, et al. Social capital, depressive symptoms, and HIV viral suppression among young black, gay, bisexual and other men who have sex with men living with HIV. AIDS Behav. 2018;22(9):3024–32.PubMedPubMedCentralCrossRef
96.
Fawzi MCS, et al. Healthy Options: study protocol and baseline characteristics for a cluster randomized controlled trial of group psychotherapy for perinatal women living with HIV and depression in Tanzania. BMC Public Health. 2020;20(1):1–10.
97.
Poteat TC, et al. Depression, sexual behavior, and HIV treatment outcomes among transgender women, cisgender women and men who have sex with men living with HIV in Brazil and Thailand: a short report. AIDS Care. 2020;32(3):310–5.PubMedCrossRef
98.
Peltzer K, et al. The effect of male involvement and a prevention of mother-to-child transmission (PMTCT) intervention on depressive symptoms in perinatal HIV-infected rural South African women. Arch Women's Mental Health. 2020;23(1):101–11.CrossRef
99.
Mo PK, et al. The Moderating Role of Social Support on the Relationship Between Anxiety, Stigma, and Intention to Use Illicit Drugs Among HIV-Positive Men Who Have Sex with Men. AIDS Behav. 2020;24(1):55–64.PubMedCrossRef
100.
Luo R, et al. The Disparities in Mental Health Between Gay and Bisexual Men Following Positive HIV Diagnosis in China: A One-Year Follow-Up Study. Int J Environ Res Public Health. 2020;17(10):3414.PubMedCentralCrossRef
101.
Kelbert E, et al. Suicide risk in people living with AIDS/HIV: the effect of childhood trauma is mediated by mental disorders and social vulnerability. AIDS Care. 2020;32(4):512–7.PubMedCrossRef
102.
Yan H, et al. Association between perceived HIV stigma, social support, resilience, self-esteem, and depressive symptoms among HIV-positive men who have sex with men (MSM) in Nanjing, China. Aids Care. 2019;31(9):1069–76.PubMedCrossRef
103.
Wang Y-Y, et al. Suicidality and clinical correlates in Chinese men who have sex with men (MSM) with HIV infection. Psychol Health Med. 2019;24(2):137–43.PubMedCrossRef
104.
Wang N, et al. Negative associations between general self-efficacy and anxiety/depression among newly HIV-diagnosed men who have sex with men in Beijing,China. Aids Care. 2019;31(5):629–35.PubMedCrossRef
105.
Rodriguez VJ, et al. The role of social support in the association between childhood trauma and depression among HIV-infected and HIV-uninfected individuals. Int J STD AIDS. 2019;30(1):29–36.PubMedCrossRef
106.
Jones DL, et al. The use of efavirenz during pregnancy is associated with suicidal ideation in postpartum women in rural South Africa. AIDS Behav. 2019;23(1):126–31.PubMedPubMedCentralCrossRef
107.
Harrington BJ, et al. Prevalence and factors associated with antenatal depressive symptoms among women enrolled in Option B+ antenatal HIV care in Malawi: a cross-sectional analysis. J Ment Health. 2019;28(2):198–205.PubMedCrossRef
108.
Getaneh M, et al. Two-third of inmates were depressed among HIV positive prisoners at central prison (Kaliti), Addis Ababa, Ethiopia. BMC Res Notes. 2019;12(1):1–6.CrossRef
109.
110.
Xiaowen W, et al. Depression and anxiety mediate perceived social support to predict health-related quality of life in pregnant women living with HIV. AIDS Care. 2018;30(9):1147–55.PubMedCrossRef
111.
Sauceda JA, et al. Acculturation, family cohesion, and mental health among Latinos living with HIV on the US-Mexico border. Cult Divers Ethn Minor Psychol. 2018;24(3):453.CrossRef
112.
Rodriguez VJ, et al. Correlates of suicidal ideation during pregnancy and postpartum among women living with HIV in rural South Africa. AIDS Behav. 2018;22(10):3188–97.PubMedPubMedCentralCrossRef
113.
Polansky M, et al. Pregnancy planning, timing, happiness and depressive symptoms among low-income women living with and without HIV. J Reprod Infant Psychol. 2018;36(3):222–34.PubMedCrossRef
114.
Mo PK-H, Lau JT-F, Wu X. Relationship between illness representations and mental health among HIV-positive men who have sex with men. AIDS Care. 2018;30(10):1246–51.PubMedCrossRef
115.
Harrington BJ, et al. Probable antenatal depression at antiretroviral initiation and postpartum viral suppression and engagement in Option B+. AIDS (London, England). 2018;32(18):2827.CrossRef
116.
Harrington BJ, et al. Prevalence and incidence of probable perinatal depression among women enrolled in Option B+ antenatal HIV care in Malawi. J Affect Disord. 2018;239:115–22.PubMedPubMedCentralCrossRef
117.
Cherenack EM, et al. Avoidant coping mediates the relationship between self-efficacy for HIV disclosure and depression symptoms among men who have sex with men newly diagnosed with HIV. AIDS Behav. 2018;22(10):3130–40.PubMedPubMedCentralCrossRef
118.
Angrand RC, et al. Depression in perinatally HIV-infected pregnant women compared to non-perinatally HIV-infected and HIV-uninfected pregnant women. AIDS Care. 2018;30(9):1168–72.PubMedCrossRef
119.
Ware D, et al. The longitudinal impact of employment, retirement and disability status on depressive symptoms among men living with HIV in the Multicenter AIDS Cohort Study. PLoS One. 2020;15(10):e0239291.PubMedPubMedCentralCrossRef
120.
Perazzo JD, et al. Depression and social capital in people living with HIV. J Psychiatr Ment Health Nurs. 2020;27(1):54–61.PubMedCrossRef
121.
Nagata JM, et al. Presence of older adolescents in the household is associated with depressive symptoms among women living with HIV in Kenya. AIDS Behav. 2020;24(12):3574–8.PubMedPubMedCentralCrossRef
122.
123.
Whittle HJ, et al. Food insecurity is associated with anxiety, stress, and symptoms of posttraumatic stress disorder in a cohort of women with or at risk of HIV in the United States. J Nutr. 2019;149(8):1393–403.PubMedPubMedCentralCrossRef
124.
Tuthill EL, et al. Persistent food insecurity is associated with adverse mental health among women living with or at risk of HIV in the United States. J Nutr. 2019;149(2):240–8.PubMedPubMedCentralCrossRef
125.
Huang Y, et al. Role of psychosocial status in predicting health-related quality of life at 1-year follow-up among newly diagnosed people living with HIV. PLoS One. 2019;14(10):e0224322.PubMedPubMedCentralCrossRef
126.
Hanass-Hancock J, Carpenter B, Myezwa H. The missing link: exploring the intersection of gender, capabilities, and depressive symptoms in the context of chronic HIV. Women Health. 2019;59(10):1212–26.PubMedCrossRef
127.
Wang Y-Y, et al. Prevalence of depressive syndrome and their association with demographic and clinical characteristics in Chinese HIV patients. AIDS Care. 2018;30(11):1388–92.PubMedCrossRef
128.
Seffren V, et al. Association between coping strategies, social support, and depression and anxiety symptoms among rural Ugandan women living with HIV/AIDS. AIDS Care. 2018;30(7):888–95.PubMedCrossRef
129.
Palar K, et al. Food insecurity, internalized stigma, and depressive symptoms among women living with HIV in the United States. AIDS Behav. 2018;22(12):3869–78.PubMedPubMedCentralCrossRef
130.
Kalomo EN. Associations between HIV-related stigma, self-esteem, social support, and depressive symptoms in Namibia. Aging Ment Health. 2018;22(12):1570–6.PubMedCrossRef
131.
Chenneville T, et al. Psychological factors related to resilience and vulnerability among youth with HIV in an integrated care setting. AIDS Care. 2018;30(sup4):5–11.PubMedCrossRef
132.
Stockton MA, et al. The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy in Malawi. PLoS One. 2020;15(5):e0231872.PubMedPubMedCentralCrossRef
133.
Zuñiga JA, et al. Biomarkers panels can predict fatigue, depression and pain in persons living with HIV: A pilot study. Appl Nurs Res. 2020;52:151224.PubMedCrossRef
134.
Shi Y, et al. CD4+ T Cell Count, Sleep, Depression, and Anxiety in People Living With HIV: A Growth Curve Mixture Modeling. J Assoc Nurses AIDS Care. 2020;31(5):535.PubMedPubMedCentralCrossRef
135.
Paolillo EW, et al. Cumulative burden of depression and neurocognitive decline among persons with HIV: a longitudinal study. JAIDS J Acquir Immune Defic Syndr. 2020;84(3):304–12.PubMedCrossRef
136.
Rubin LH, et al. Elevated depressive symptoms are a stronger predictor of executive dysfunction in HIV-infected women than men. J Acquir Immune Defic Syndr (1999). 2019;81(3):274.CrossRef
137.
De Francesco D, et al. Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls. HIV Med. 2019;20(4):274–85.PubMedPubMedCentralCrossRef
138.
Bengtson AM, et al. Depressive symptoms and engagement in human immunodeficiency virus care following antiretroviral therapy initiation. Clin Infect Dis. 2019;68(3):475–81.PubMedCrossRef
139.
Ursoiu F, et al. The association between hiv clinical disease severity and psychiatric disorders as seen in western romania. AIDS Care. 2018;30(11):1368–71.PubMedCrossRef
140.
Tymchuk S, et al. Associations between depressive symptomatology and neurocognitive impairment in HIV/AIDS. Can J Psychiatry. 2018;63(5):329–36.PubMedCrossRef
141.
Owora AH. Major depression disorder trajectories and HIV disease progression: results from a 6-year outpatient clinic cohort. Medicine. 2018:97(12).
142.
Nyongesa MK, et al. Neurocognitive and mental health outcomes and association with quality of life among adults living with HIV: a cross-sectional focus on a low-literacy population from coastal Kenya. BMJ Open. 2018;8(9):e023914.PubMedPubMedCentralCrossRef
143.
Fekete EM, Williams SL, Skinta MD. Internalised HIV-stigma, loneliness, depressive symptoms and sleep quality in people living with HIV. Psychol Health. 2018;33(3):398–415.PubMedCrossRef
144.
Musinguzi K, et al. Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda. BMC Immunol. 2018;19(1):1–7.PubMedPubMedCentralCrossRef
145.
Martínez-Banfi M, et al. Neuropsychological performance in patients with asymptomatic HIV-1 infection. AIDS Care. 2018;30(5):623–33.PubMedCrossRef
146.
Aibibula W, et al. Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people. AIDS Care. 2018;30(5):643–9.PubMedCrossRef
147.
van Luenen S, et al. Moderators of the effect of guided online self-help for people with HIV and depressive symptoms. AIDS Care. 2020;32(8):942–8.PubMedCrossRef
148.
Nakimuli-Mpungu E, et al. Effectiveness and cost-effectiveness of group support psychotherapy delivered by trained lay health workers for depression treatment among people with HIV in Uganda: a cluster-randomised trial. Lancet Glob Health. 2020;8(3):e387–98.PubMedCrossRef
149.
Horvat Davey C, et al. The relationship of cardiorespiratory function, fatigue and depressive symptoms in PLHIV. AIDS Care. 2020;32(7):877–81.PubMedCrossRef
150.
Han S, et al. Dataset of cognitive behavioral intervention for persons living with HIV in China: A randomized pilot trial. Data Brief. 2020;30:105459.PubMedPubMedCentralCrossRef
151.
Gunzler D, et al. Depressive symptom trajectories among people living with HIV in a collaborative care program. AIDS Behav 2019: p. 1-11.
152.
Wonde M, et al. The magnitude of suicidal ideation, attempts and associated factors of HIV positive youth attending ART follow ups at St. Paul’s hospital Millennium Medical College and St. Peter’s specialized hospital, Addis Ababa, Ethiopia, 2018. PLoS One. 2019;14(11):e0224371.PubMedPubMedCentralCrossRef
153.
Li Y, et al. Mechanisms and effects of a WeChat-based intervention on suicide among people living with HIV and depression: Path model analysis of a randomized controlled trial. J Med Internet Res. 2019;21(11):e14729.PubMedPubMedCentralCrossRef
154.
van Luenen S, et al. Guided internet-based intervention for people with HIV and depressive symptoms: a randomised controlled trial in the Netherlands. Lancet HIV. 2018;5(9):e488–97.PubMedCrossRef
155.
Tull MT, et al. An initial open trial of a brief behavioral activation treatment for depression and medication adherence in HIV-infected patients. Behav Modif. 2018;42(2):196–209.PubMedCrossRef
156.
Heckman TG, et al. A randomized clinical trial showing persisting reductions in depressive symptoms in HIV-infected rural adults following brief telephone-administered interpersonal psychotherapy. Ann Behav Med. 2018;52(4):299–308.PubMedPubMedCentralCrossRef
157.
158.
DiPrete BL, et al. Measurement of depression treatment among patients receiving HIV primary care: Whither the truth? J Affect Disord. 2018;230:50–5.PubMedPubMedCentralCrossRef
159.
Anderson T, et al. Working alliance, interpersonal problems, and depressive symptoms in tele-interpersonal psychotherapy for HIV-infected rural persons: Evidence for indirect effects. J Clin Psychol. 2018;74(3):286–303.PubMedCrossRef
160.
Andersen LS, et al. A pilot study of a nurse-delivered cognitive behavioral therapy intervention (Ziphamandla) for adherence and depression in HIV in South Africa. J Health Psychol. 2018;23(6):776–87.PubMedCrossRef
161.
Abas M, et al. Feasibility and acceptability of a task-shifted intervention to enhance adherence to HIV medication and improve depression in people living with HIV in Zimbabwe, a low income country in sub-Saharan Africa. AIDS Behav. 2018;22(1):86–101.PubMedCrossRef
162.
163.
Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.PubMedCrossRef
164.
Stewart JC, et al. Associations of Total, Cognitive/Affective, and Somatic Depressive Symptoms and Antidepressant Use With Cardiovascular Disease–Relevant Biomarkers in HIV: Veterans Aging Cohort Study. Psychosom Med. 2020;82(5):461–70.PubMedPubMedCentralCrossRef
165.
Lu H, et al. Inflammation and risk of depression in HIV: prospective findings from the Multicenter AIDS Cohort Study. Am J Epidemiol. 2019;188(11):1994–2003.PubMedPubMedCentralCrossRef
166.
Saloner R, et al. Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease. Brain Behav Immun. 2020;90:353–63.PubMedPubMedCentralCrossRef
167.
168.
Rubin LH, Maki PM. HIV, depression, and cognitive impairment in the era of effective antiretroviral therapy. Curr HIV/AIDS Rep. 2019;16(1):82–95.PubMedPubMedCentralCrossRef
169.
Caballero-Suárez NP, et al. Effects of cognitive-behavioural therapy on anxiety, depression and condom use in people with HIV in Mexico City: a pilot study. Psychol Health Med. 2019;24(1):115–25.PubMedCrossRef
170.
Javadi D, et al. Applying systems thinking to task shifting for mental health using lay providers: A review of the evidence. Global Mental Health. 2017;4:e14.PubMedPubMedCentralCrossRef
Metadaten
Titel
Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV
verfasst von
Jacqueline Hoare
Tatum Sevenoaks
Bulelwa Mtukushe
Taryn Williams
Sarah Heany
Nicole Phillips
Publikationsdatum
18.11.2021
Verlag
Springer US
Erschienen in
Current HIV/AIDS Reports / Ausgabe 6/2021
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-021-00583-w

Weitere Artikel der Ausgabe 6/2021

Current HIV/AIDS Reports 6/2021 Zur Ausgabe

Central Nervous System and Cognition (S Spudich, Section Editor)

Central Nervous System Effects of COVID-19 in People with HIV Infection

The Science of Prevention (R Heffron and K Ngure, Section Editors)

Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?

Central Nervous System and Cognition (S Spudich, Section Editor)

Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era

Correction

Correction to: Interventions Addressing Depression and HIV-Related Outcomes in People with HIV

Central Nervous System and Cognition (S Spudich, Section Editor)

CNS Considerations in ART Simplification Strategies

Central Nervous System and Cognition (SS Spudich, Section Editor)

Validity of Digital Assessments in Screening for HIV-Related Cognitive Impairment: a Review

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise